Rely on Stemulate^®

As cell therapies and regenerative medicine studies move rapidly forward, you need a culture media supplement you can rely on for safety, consistency, and performance. Stemulate supports the expansion of multiple types of cells in vitro, including endothelial colony forming cells, fibroblasts, and mesenchymal stem cells (MSCs) from a variety of tissue sources such as adipose, bone marrow, and placenta.

1. Research Grade

2. Clinical Grade

Safety

• Human cells benefit from human culture media supplements.
• Stemulate does not contain animal proteins.
• Stemulate contains human donor platelets obtained from AABB accredited blood centers.
• Donor platelets are tested for infectious diseases using the criteria for testing transfusable blood products.
• The finished clinical grade Stemulate product meets 
• Stemulate is produced according to GMP methodology in a purpose built facility.
• Stemulate has U.S. Patent US9757430

Consistency

• Stemulate is produced in large batches (> 20 liters) for minimal variation from lot to lot.
• The reliable and consistent supply of human donor platelets helps stabilize availability and pricing.
• Cook Medical is a global medical technology company that recently celebrated 50 years in business.

Performance

• Stemulate has been tested with multiple types of cells in vitro. These cells include mesenchymal stem cells (MSCs) from a variety of tissue sources (such as adipose, bone marrow, and placenta); endothelial colony forming cells; and fibroblasts. (Data on file.)
• Using Stemulate at concentrations of 2.5%, 5%, and 10% supported cell proliferation at levels comparable to fetal bovine serum (FBS). (Data on file.)
• Stemulate is bottled without heparin.